Topics

RenovaCare Chairman Invests $15.5 Million to Fund SkinGun™ Regulatory Submissions and Clinical Trials

08:30 EST 29 Nov 2018 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
RenovaCare, Inc., (Symbol: RCAR; www.renovacareinc.com) today announced an equity financing for $15.5 million from Kalen Capital Corporation, the family office of Mr. Harmel S. Rayat, majority shareholder and Chairman of RenovaC...

Other Sources for this Article

Amit Singh, 1-888-398-0202
contact@renovacareinc.com

NEXT ARTICLE

More From BioPortfolio on "RenovaCare Chairman Invests $15.5 Million to Fund SkinGun™ Regulatory Submissions and Clinical Trials"

Quick Search

Relevant Topics

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...

Complementary and Alternative Medicine
Alternative medicine are whole medical systems that did not fit with conventional medicine as they have completely different philosophies and ideas on the causes of disease, methods of diagnosis and approaches to treatment. Although often overlapping, co...